Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Plattel WJ"'
Autor:
Juul SJ; Department of Oncology, Copenhagen University Hospital-Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. sidsel.jacobsen.juul@regionh.dk., Rossetti S; Department of Haematology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Aleman BMP; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leeuwen FE; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Kaaij MAE; Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands., Giusti F; EORTC Headquarters, Brussels, Belgium.; Sciensano, Brussels, Belgium., Meijnders P; Department of Radiation Oncology, Iridium Network, University of Antwerp, Antwerp, Belgium., Raemaekers JMM; Department of Haematology, Radboud University Medical Center, Nijmegen, The Netherlands., Kluin-Nelemans HC; Department of Haematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Spina M; Division of Medical Oncology and Immune-Related Tumors, IRCCS Centro Di Riferimento Oncologico Di Aviano (CRO), IRCCS, Aviano, Italy., Krzisch D; AP-HP, Hôpital Saint-Louis, Hemato-Oncologie, DMU DHI, Université de Paris, F-75010, Paris, France., Bigenwald C; Department of Haematology, Institute Gustave Roussy, Villejuif, France., Stamatoullas A; Department of Haematology, Centre Henri Becquerel, Rouen, France., André M; Department of Haematology, CHU UCL NAMUR, Yvoir, Belgium., Plattel WJ; Department of Haematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Hutchings M; Department of Haematology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Maraldo MV; Department of Oncology, Copenhagen University Hospital-Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.
Autor:
Rossetti S; Department of Hematology, Center for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Juul SJ; Department of Clinical Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., van der Kaaij MAE; Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands., Fortpied C; EORTC Headquarters, Brussels, Belgium., Meijnders P; Department of Radiation Oncology, Iridium Network, University of Antwerp, Antwerpen, Belgium., Aleman BMP; Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Raemaekers JMM; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Kluin-Nelemans HC; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Spina M; Division of Medical Oncology and Immunerelated tumors, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Fermé C; Department of Hematology, Gustave Roussy, Villejuif, France., Renaud L; Department of Hemato-Oncology, Hôpital Saint-Louis, DMU DHI; Université de Paris, Paris, France., Casasnovas O; Department of Hematology, CHU Dijon-Bourgogne, Dijon, France., Stamatoullas A; Department of Hematology, Centre Henri Becquerel, Rouen, France., Plattel WJ; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Hutchings M; Department of Hematology, Center for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Maraldo MV; Department of Clinical Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug 12, pp. 1-5. Date of Electronic Publication: 2024 Aug 12.
Autor:
Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Huisman F; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Hematology, Treant Hospital, Emmen, The Netherlands., Meeuwes FO; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Hematology, Treant Hospital, Emmen, The Netherlands., van der Poel MWM; Division of Hematology, Department of Interne Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Böhmer L; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle, The Netherlands., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., Huls G; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2024 Jul 23; Vol. 8 (14), pp. 3619-3628.
Autor:
Neppelenbroek SIM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Geurts YM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Rademakers SE; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., de Weijer RJ; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Schippers MGA; Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands., Ta BDP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zijlstra JM; Department of Hematology, Amsterdam UMC, Location Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Maazen RWM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Nijziel MR; Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital, Eindhoven, the Netherlands., Ong F; Department of Radiotherapy, Medisch Spectrum Twente, Enschede, the Netherlands., Schimmel EC; Department of Radiotherapy, Radiotherapiegroep, Arnhem, the Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, the Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Böhmer LH; Department of Hematology, Haga Teaching Hospital, Den Haag, the Netherlands., Muller K; Department of Radiotherapy, Radiotherapiegroep, Deventer, the Netherlands., Koene HR; Department of Hematology, St Antonius Hospital, Nieuwegein, the Netherlands., Te Boome LCJ; Department of Hematology, Haaglanden Medical Center, Den Haag, the Netherlands., Bilgin YM; Department of Internal Medicine, Admiraal De Ruyter Hospital, Goes, the Netherlands., de Jongh E; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Janus CPM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 01; Vol. 42 (16), pp. 1903-1913. Date of Electronic Publication: 2024 Feb 15.
Autor:
Juul SJ; Department of Oncology, Rigshospitalet, Copenhagen, Denmark. sidsel.jacobsen.juul@regionh.dk., Rossetti S; Department of Haematology, Rigshospitalet, Copenhagen, Denmark., Kicinski M; EORTC Headquarters, Brussels, Belgium., van der Kaaij MAE; Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands., Giusti F; EORTC Headquarters, Brussels, Belgium.; Belgian Cancer Registry, Brussels, Belgium., Meijnders P; Department of Radiation Oncology, Iridium Network, University of Antwerp, Antwerpen, Belgium., Aleman BMP; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Raemaekers JMM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Kluin-Nelemans HC; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Spina M; Division of Medical Oncology and Immunerelated Tumors, Centro Di Riferimento Oncologico Di Aviano (CRO), IRCCS, Aviano, Italy., Fermé C; Department of Hematology, Gustave Roussy, Villejuif, France., Renaud L; AP-HP, Hôpital Saint-Louis, Hemato-Oncologie, DMU DHI; Université de Paris, F-75010, Paris, France., Casasnovas O; Department of Hematology, CHU Dijon-Bourgogne, Dijon, France., Stamatoullas A; Department of Hematology, Centre Henri Becquerel, Rouen, France., André M; Department of Hematology, CHU UCL NAMUR, Yvoir, Belgium., Le Bras F; Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor, Créteil, France., Plattel WJ; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Henry-Amar M; Centre de Traitement des Données du Cancéropôle Nord-Ouest, Centre François Baclesse, Caen, France., Hutchings M; Department of Haematology, Rigshospitalet, Copenhagen, Denmark., Maraldo MV; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 Jun; Vol. 18 (3), pp. 727-738. Date of Electronic Publication: 2022 Nov 28.
Autor:
Geurts YM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam., Neppelenbroek SIM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam., Janus CPM; Department of Radiotherapy, Erasmus Medical Centre, Rotterdam., Krol ADG; Department of Radiation Oncology, Leiden University Medical Centre, Leiden., van Spronsen DJ; Department of Hematology, Radboud University Medical Centre, Nijmegen., Plattel WJ; Department of Hematology, University Medical Centre Groningen, Groningen., Roesink JM; Department of Radiotherapy, University Medical Centre Utrecht, Utrecht., Verschueren KMS; Department of Radiation Oncology, Institute Verbeeten, Tilburg., Zijlstra JM; Department of Hematology, Amsterdam UMC location Vrije Universiteit, Cancer Centre Amsterdam, Amsterdam., Koene HR; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein., Nijziel MR; Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital, Eindhoven., Schimmel EC; Radiotherapiegroep, Arnhem., de Jongh E; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht., Ong F; Department of Radiotherapy, Medisch Spectrum Twente, Enschede., Te Boome LCJ; Department of Hematology, Haaglanden Medical Centre, The Hague., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden., Böhmer LH; Department of Hematology, Haga Teaching Hospital, The Hague., Ta BDP; Department of Radiation Oncology (MAASTRO), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht., Visser HPJ; Department of Hematology, Noordwest Ziekenhuisgroep Alkmaar, Alkmaar., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft., Bilgin YM; Department of Internal Medicine, ADRZ, Goes., Muller K; Radiotherapiegroep, Deventer., van Kampen D; Zuidwest Radiotherapeutisch Instituut, Vlissingen., So-Osman C; Department of Hematology, Erasmus Medical Centre, Rotterdam; Unit Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam., Vermaat JSP; Department of Hematology, Leiden University Medical Centre, Leiden., de Weijer RJ; Department of Hematology, University Medical Centre Utrecht, Utrecht., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Centre Amsterdam and LYMMCARE, Amsterdam, The Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam. Electronic address: m.schaapveld@nki.nl.
Publikováno v:
ESMO open [ESMO Open] 2024 Feb; Vol. 9 (2), pp. 102248. Date of Electronic Publication: 2024 Feb 12.
Autor:
van Bladel DAG; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Stevens WBC; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Kroeze LI; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., de Groen RAL; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., de Groot FA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van der Last-Kempkes JLM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Berendsen MR; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Rijntjes J; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Luijks JACW; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Bonzheim I; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., van der Spek E; Department of Hematology, Rijnstate Hospital, Arnhem, The Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Pruijt JFM; Department of Hematology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., de Jonge-Peeters SDPWM; Department of Hematology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Velders GA; Department of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands., Lensen C; Department of Hematology, Bernhoven Hospital, Uden, The Netherlands., van Bladel ER; Department of Internal Medicine, Slingeland Hospital, Doetinchem, The Netherlands., Federmann B; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.; Department of Translational Immunology, German Cancer Research Center, Medical Hospital Tübingen, Tübingen, Germany., Hoevenaars BM; Department of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Pastorczak A; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland., van der Werff Ten Bosch J; Department of Pediatric Hematology and Oncology, University Hospital Brussels, Brussels, Belgium.; Department of Pediatrics, Paola Children's Hospital, Antwerp, Belgium., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Nooijen PTGA; Pathology-DNA, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Hebeda KM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Fend F; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Diepstra A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., van Krieken JHJM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Groenen PJTA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van den Brand M; Pathology-DNA, Rijnstate Hospital, Arnhem, The Netherlands., Scheijen B; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2023 Oct 10; Vol. 7 (19), pp. 5911-5924.
Autor:
Veltmaat N; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Zhong Y; Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., de Jesus FM; Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Tan GW; Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Bult JAA; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Terpstra MM; Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands., Stevens WBC; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands., Mous R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Chamuleau MED; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Noordzij W; Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Verschuuren EAM; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Kok K; Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Kluiver JL; Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Plattel WJ; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., van den Berg A; Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Nijland M; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. m.nijland@umcg.nl.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2023 Sep 14; Vol. 16 (1), pp. 104. Date of Electronic Publication: 2023 Sep 14.
Autor:
Bult JAA; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Huisman F; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Zhong Y; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands., Veltmaat N; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Kluiver J; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands., Tonino SH; Department of Hematology, Amsterdam University Medical Center, Amsterdam, the Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Chamuleau MED; Department of Hematology, Amsterdam University Medical Center, Amsterdam, the Netherlands., Diepstra A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands., van den Berg A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. m.nijland@umcg.nl.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Sep 01; Vol. 13 (1), pp. 130. Date of Electronic Publication: 2023 Sep 01.
Autor:
Juul SJ; Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Rossetti S; Department of Haematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Kicinski M; EORTC Headquarters, Brussels, Belgium., van der Kaaij MAE; Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands., Giusti F; EORTC Headquarters, Brussels, Belgium (Present affiliation: Belgian Cancer Registry, Brussels, Belgium)., Meijnders P; Department of Radiation Oncology, Iridium Network, University of Antwerp, Antwerpen, Belgium., Aleman BMP; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Raemaekers JMM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Kluin-Nelemans HC; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Spina M; Division of Medical Oncology and Immunerelated tumors, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Fermé C; Department of Hematology, Gustave Roussy, Villejuif, France., Renaud L; AP-HP, Hôpital Saint-Louis, Hemato-oncologie, DMU DHI; Université de Paris, Paris, France., Casasnovas O; Department of Hematology, CHU Dijon-Bourgogne, Dijon, France., Stamatoullas A; Department of Hematology, Centre Henri Becquerel, Rouen, France., André M; Department of Hematology, CHU UCL NAMUR, Yvoir, Belgium., Le Bras F; Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor, Créteil, France., Plattel WJ; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Henry-Amar M; Centre de Traitement des Données du Cancéropôle Nord-Ouest, Centre François Baclesse, Caen, France., Hutchings M; Department of Haematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Maraldo MV; Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Jul; Vol. 62 (7), pp. 744-752. Date of Electronic Publication: 2023 Apr 11.